|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Costello RT, Mallet F, Gaugler B, et al:
Human acute myeloid leukemia CD34+/CD38−
progenitor cells have decreased sensitivity to chemotherapy and
Fas-induced apoptosis, reduced immunogenicity, and impaired
dendritic cell transformation capacities. Cancer Res. 60:4403–4411.
2000.PubMed/NCBI
|
|
4
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
5
|
Guzman ML, Swiderski CF, Howard DS, et al:
Preferential induction of apoptosis for primary human leukemic stem
cells. Proc Natl Acad Sci USA. 99:16220–16225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
7
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
|
|
12
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dontu G, Abdallah WM, Foley JM, et al: In
vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamamoto K, Yahara N, Gondo T, Ishihara T
and Oka M: Establishment and characterization of a new human
pancreatic cancer cell line, YPK-1. Bull Yamaguchi Med Sch.
49:33–42. 2002.
|
|
15
|
Tsunedomi R, Iizuka N, Tamesa T, et al:
Decreased ID2 promotes metastatic potentials of hepatocellular
carcinoma by altering secretion of vascular endothelial growth
factor. Clin Cancer Res. 14:1025–1031. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsunedomi R, Iizuka N, Harada S and Oka M:
Susceptibility of hepatoma-derived cells to histone deacetylase
inhibitors is associated with ID2 expression. Int J Oncol.
42:1159–1166. 2013.PubMed/NCBI
|
|
17
|
Nagano O, Okazaki S and Saya H: Redox
regulation in stem-like cancer cells by CD44 variant isoforms.
Oncogene. 32:5191–5198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanabe KK, Ellis LM and Saya H: Expression
of CD44R1 adhesion molecule in colon carcinomas and metastases.
Lancet. 341:725–726. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abdullah LN and Chow EK: Mechanisms of
chemoresistance in cancer stem cells. Clin Transl Med. 2:32013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dick JE: Stem cell concepts renew cancer
research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prat A, Parker JS, Karginova O, et al:
Phenotypic and molecular characterization of the claudin-low
intrinsic subtype of breast cancer. Breast Cancer Res. 12:R682010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morel AP, Lievre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mor G, Yin G, Chefetz I, Yang Y and Alvero
A: Ovarian cancer stem cells and inflammation. Cancer Biol Ther.
11:708–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiou SH, Yu CC, Huang CY, et al: Positive
correlations of Oct-4 and Nanog in oral cancer stem-like cells and
high-grade oral squamous cell carcinoma. Clin Cancer Res.
14:4085–4095. 2008. View Article : Google Scholar
|
|
28
|
Lee J, Kotliarova S, Kotliarov Y, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hueng DY, Sytwu HK, Huang SM, Chang C and
Ma HI: Isolation and characterization of tumor stem-like cells from
human meningiomas. J Neurooncol. 104:45–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhong Y, Guan K, Guo S, et al: Spheres
derived from the human SK-RC-42 renal cell carcinoma cell line are
enriched in cancer stem cells. Cancer Lett. 299:150–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pollard SM, Yoshikawa K, Clarke ID, et al:
Glioma stem cell lines expanded in adherent culture have
tumor-specific phenotypes and are suitable for chemical and genetic
screens. Cell Stem Cell. 4:568–580. 2009. View Article : Google Scholar
|
|
32
|
Ziober AF, Falls EM and Ziober BL: The
extracellular matrix in oral squamous cell carcinoma: friend or
foe? Head Neck. 28:740–749. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Timpl R, Rohde H, Robey PG, Rennard SI,
Foidart JM and Martin GR: Laminin - a glycoprotein from basement
membranes. J Biol Chem. 254:9933–9937. 1979.PubMed/NCBI
|
|
34
|
Calabrese C, Poppleton H, Kocak M, et al:
A perivascular niche for brain tumor stem cells. Cancer Cell.
11:69–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takeishi S, Matsumoto A, Onoyama I, Naka
K, Hirao A and Nakayama KI: Ablation of Fbxw7 eliminates
leukemia-initiating cells by preventing quiescence. Cancer Cell.
23:347–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
